ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,814Medicare Part D Prescriptions Filled, Including Refills

Rank: 280 out of 783

$480K Total Retail Price of All Prescriptions

Rank: 282 out of 783

323 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
18% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

15% of this provider’s 323 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 6,490 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
SIMVASTATIN 315 293 1 3
LEVOTHYROXINE SODIUM 292 240 2 1
OMEPRAZOLE 292 275 2 6
FUROSEMIDE 266 247 4 7
PRAVASTATIN SODIUM 204 157 5 14
HYDROCODONE-ACETAMINOPHEN 187 150 S3 6 2
METOPROLOL SUCCINATE 180 174 7 13
GABAPENTIN 177 134 8 15
METFORMIN HCL 177 131 8 8
ZOLPIDEM TARTRATE 163 134 10 23
AMLODIPINE BESYLATE 141 119 11 5
TRIAMTERENE-HCTZ 141 133 11 42
SULINDAC 132 129 13 272
TRAMADOL HCL 119 72 14 20
METOPROLOL TARTRATE 118 108 15 9
ATORVASTATIN CALCIUM 117 83 16 11
MELOXICAM 115 91 17 37
LISINOPRIL-HYDROCHLOROTHIAZIDE 86 86 18 33
CITALOPRAM HBR 83 64 19 19
WARFARIN SODIUM 83 75 19 10
ESCITALOPRAM OXALATE 83 65 19 54
LISINOPRIL 80 48 22 4
ALLOPURINOL 80 67 22 31
NAMENDA 78 78 24 32
CRESTOR 76 74 25 27
POTASSIUM CHLORIDE 72 66 26 16
AZITHROMYCIN 72 52 26 41
PANTOPRAZOLE SODIUM 72 57 26 30
CELEBREX 64 52 29 93
ACTOS 63 60 30 149
SPIRONOLACTONE 61 51 31 57
DOXAZOSIN MESYLATE 61 58 31 87
ATENOLOL 61 61 31 17
KLOR-CON M20 57 45 34 48
SYNTHROID 55 55 35 47
TAMSULOSIN HCL 55 55 35 26
ALENDRONATE SODIUM 54 40 37 25
HYDROCHLOROTHIAZIDE 53 44 38 12
CLOPIDOGREL 52 48 39 29
NEXIUM 51 46 40 28
METOLAZONE 50 48 41 186
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 6, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.